HEADER SIGNALING PROTEIN 28-AUG-17 5OVI TITLE RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX TITLE 2 WITH SMALL MOLECULE INHIBITOR BAY-293 (COMPOUND 23) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SON OF SEVENLESS HOMOLOG 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SOS-1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SOS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GUANINE EXCHANGE FACTOR, GEF, INHIBITOR, SOS1, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.C.HILLIG,B.SAUTIER,J.SCHROEDER,D.MOOSMAYER,A.HILPMANN,C.M.STEGMANN, AUTHOR 2 H.BRIEM,U.BOEMER,J.WEISKE,V.BADOCK,K.PETERSEN,J.KAHMANN,D.WEGENER, AUTHOR 3 N.BOHNKE,K.EIS,K.GRAHAM,L.WORTMANN,F.VON NUSSBAUM,B.BADER REVDAT 3 17-JAN-24 5OVI 1 REMARK REVDAT 2 20-FEB-19 5OVI 1 JRNL REVDAT 1 06-FEB-19 5OVI 0 JRNL AUTH R.C.HILLIG,B.SAUTIER,J.SCHROEDER,D.MOOSMAYER,A.HILPMANN, JRNL AUTH 2 C.M.STEGMANN,N.D.WERBECK,H.BRIEM,U.BOEMER,J.WEISKE,V.BADOCK, JRNL AUTH 3 J.MASTOURI,K.PETERSEN,G.SIEMEISTER,J.D.KAHMANN,D.WEGENER, JRNL AUTH 4 N.BOHNKE,K.EIS,K.GRAHAM,L.WORTMANN,F.VON NUSSBAUM,B.BADER JRNL TITL DISCOVERY OF POTENT SOS1 INHIBITORS THAT BLOCK RAS JRNL TITL 2 ACTIVATION VIA DISRUPTION OF THE RAS-SOS1 INTERACTION. JRNL REF PROC. NATL. ACAD. SCI. V. 116 2551 2019 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 30683722 JRNL DOI 10.1073/PNAS.1812963116 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 28708 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1511 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2067 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3870 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 294 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.69000 REMARK 3 B22 (A**2) : -2.09000 REMARK 3 B33 (A**2) : 0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.286 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.216 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.937 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4066 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3930 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5505 ; 1.120 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9041 ; 0.882 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 478 ; 4.940 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 207 ;32.167 ;23.768 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 748 ;14.532 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 35 ;14.019 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 593 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4496 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 934 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1877 ; 1.494 ; 2.788 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1876 ; 1.495 ; 2.786 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2344 ; 2.574 ; 6.252 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2345 ; 2.574 ; 6.255 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2189 ; 1.727 ; 3.043 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2189 ; 1.727 ; 3.043 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3154 ; 2.971 ; 6.683 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4847 ; 5.760 ;17.484 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4848 ; 5.759 ;17.488 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 566 A 745 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0000 0.0000 0.0000 REMARK 3 T TENSOR REMARK 3 T11: 0.3408 T22: 0.2388 REMARK 3 T33: 0.0849 T12: 0.1407 REMARK 3 T13: 0.1426 T23: 0.0614 REMARK 3 L TENSOR REMARK 3 L11: 0.9237 L22: 3.1759 REMARK 3 L33: 1.6088 L12: -0.4927 REMARK 3 L13: 0.3019 L23: -1.8494 REMARK 3 S TENSOR REMARK 3 S11: 0.1207 S12: 0.2509 S13: -0.0235 REMARK 3 S21: -0.9412 S22: -0.3833 S23: -0.4593 REMARK 3 S31: 0.5923 S32: 0.3839 S33: 0.2626 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 753 A 1044 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0000 0.0000 0.0000 REMARK 3 T TENSOR REMARK 3 T11: 0.2438 T22: 0.3344 REMARK 3 T33: 0.0895 T12: 0.0877 REMARK 3 T13: 0.0145 T23: 0.1232 REMARK 3 L TENSOR REMARK 3 L11: 0.6096 L22: 2.0625 REMARK 3 L33: 1.0035 L12: -0.1222 REMARK 3 L13: 0.1252 L23: -1.2256 REMARK 3 S TENSOR REMARK 3 S11: 0.0257 S12: 0.3371 S13: 0.2124 REMARK 3 S21: -0.5677 S22: -0.1845 S23: -0.1580 REMARK 3 S31: 0.1831 S32: 0.0761 S33: 0.1588 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5OVI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1200006427. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION NOV 1, 2016 REMARK 200 DATA SCALING SOFTWARE : XDS VERSION NOV 1, 2016 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30220 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 48.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.710 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14000 REMARK 200 FOR THE DATA SET : 5.7500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.79 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.64400 REMARK 200 FOR SHELL : 1.540 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP VERSION 11.0.02 REMARK 200 STARTING MODEL: 2II0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN CONCENTRATION 30.7 MG/ML. REMARK 280 PROTEIN BUFFER 25 MILLIMOLAR TRIS-HCL PH 7.5, 50 MILLIMOLAR NACL, REMARK 280 1 MILLIMOLAR DTT. RESERVOIR 0.1 M TRIS PH 8.5, 25 % (W/V) PEG REMARK 280 3350. CRYO BUFFER WAS RESERVOIR SUPPLEMENTED WITH 2 MILLIMOLAR REMARK 280 INHIBITOR (FROM 100 MILLIMOLAR DMSO STOCK) AND 15 % (V/V) REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.73800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.64250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.14050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.64250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.73800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.14050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 560 REMARK 465 ALA A 561 REMARK 465 MET A 562 REMARK 465 ALA A 563 REMARK 465 GLU A 564 REMARK 465 GLU A 565 REMARK 465 ASN A 591 REMARK 465 MET A 592 REMARK 465 GLN A 593 REMARK 465 PRO A 594 REMARK 465 LYS A 595 REMARK 465 ALA A 596 REMARK 465 ASN A 746 REMARK 465 GLY A 747 REMARK 465 PRO A 748 REMARK 465 GLY A 749 REMARK 465 HIS A 750 REMARK 465 ASN A 751 REMARK 465 ILE A 752 REMARK 465 PRO A 1045 REMARK 465 ARG A 1046 REMARK 465 PRO A 1047 REMARK 465 GLY A 1048 REMARK 465 THR A 1049 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 681 -61.40 -127.23 REMARK 500 HIS A 700 44.54 -141.24 REMARK 500 PHE A 754 111.29 64.09 REMARK 500 HIS A 764 -90.59 -124.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AXH A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 2003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 2004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2II0 RELATED DB: PDB REMARK 900 RELATED ID: 5OVE RELATED DB: PDB REMARK 900 RELATED ID: 5OVF RELATED DB: PDB REMARK 900 RELATED ID: 5OVG RELATED DB: PDB REMARK 900 RELATED ID: 5OVH RELATED DB: PDB REMARK 900 RELATED ID: 5OVD RELATED DB: PDB DBREF 5OVI A 560 1049 UNP Q07889 SOS1_HUMAN 560 1049 SEQADV 5OVI GLY A 560 UNP Q07889 GLN 560 ENGINEERED MUTATION SEQADV 5OVI ALA A 561 UNP Q07889 GLU 561 ENGINEERED MUTATION SEQADV 5OVI MET A 562 UNP Q07889 GLU 562 ENGINEERED MUTATION SEQADV 5OVI ALA A 563 UNP Q07889 LYS 563 ENGINEERED MUTATION SEQRES 1 A 490 GLY ALA MET ALA GLU GLU GLN MET ARG LEU PRO SER ALA SEQRES 2 A 490 ASP VAL TYR ARG PHE ALA GLU PRO ASP SER GLU GLU ASN SEQRES 3 A 490 ILE ILE PHE GLU GLU ASN MET GLN PRO LYS ALA GLY ILE SEQRES 4 A 490 PRO ILE ILE LYS ALA GLY THR VAL ILE LYS LEU ILE GLU SEQRES 5 A 490 ARG LEU THR TYR HIS MET TYR ALA ASP PRO ASN PHE VAL SEQRES 6 A 490 ARG THR PHE LEU THR THR TYR ARG SER PHE CYS LYS PRO SEQRES 7 A 490 GLN GLU LEU LEU SER LEU ILE ILE GLU ARG PHE GLU ILE SEQRES 8 A 490 PRO GLU PRO GLU PRO THR GLU ALA ASP ARG ILE ALA ILE SEQRES 9 A 490 GLU ASN GLY ASP GLN PRO LEU SER ALA GLU LEU LYS ARG SEQRES 10 A 490 PHE ARG LYS GLU TYR ILE GLN PRO VAL GLN LEU ARG VAL SEQRES 11 A 490 LEU ASN VAL CYS ARG HIS TRP VAL GLU HIS HIS PHE TYR SEQRES 12 A 490 ASP PHE GLU ARG ASP ALA TYR LEU LEU GLN ARG MET GLU SEQRES 13 A 490 GLU PHE ILE GLY THR VAL ARG GLY LYS ALA MET LYS LYS SEQRES 14 A 490 TRP VAL GLU SER ILE THR LYS ILE ILE GLN ARG LYS LYS SEQRES 15 A 490 ILE ALA ARG ASP ASN GLY PRO GLY HIS ASN ILE THR PHE SEQRES 16 A 490 GLN SER SER PRO PRO THR VAL GLU TRP HIS ILE SER ARG SEQRES 17 A 490 PRO GLY HIS ILE GLU THR PHE ASP LEU LEU THR LEU HIS SEQRES 18 A 490 PRO ILE GLU ILE ALA ARG GLN LEU THR LEU LEU GLU SER SEQRES 19 A 490 ASP LEU TYR ARG ALA VAL GLN PRO SER GLU LEU VAL GLY SEQRES 20 A 490 SER VAL TRP THR LYS GLU ASP LYS GLU ILE ASN SER PRO SEQRES 21 A 490 ASN LEU LEU LYS MET ILE ARG HIS THR THR ASN LEU THR SEQRES 22 A 490 LEU TRP PHE GLU LYS CYS ILE VAL GLU THR GLU ASN LEU SEQRES 23 A 490 GLU GLU ARG VAL ALA VAL VAL SER ARG ILE ILE GLU ILE SEQRES 24 A 490 LEU GLN VAL PHE GLN GLU LEU ASN ASN PHE ASN GLY VAL SEQRES 25 A 490 LEU GLU VAL VAL SER ALA MET ASN SER SER PRO VAL TYR SEQRES 26 A 490 ARG LEU ASP HIS THR PHE GLU GLN ILE PRO SER ARG GLN SEQRES 27 A 490 LYS LYS ILE LEU GLU GLU ALA HIS GLU LEU SER GLU ASP SEQRES 28 A 490 HIS TYR LYS LYS TYR LEU ALA LYS LEU ARG SER ILE ASN SEQRES 29 A 490 PRO PRO CYS VAL PRO PHE PHE GLY ILE TYR LEU THR ASN SEQRES 30 A 490 ILE LEU LYS THR GLU GLU GLY ASN PRO GLU VAL LEU LYS SEQRES 31 A 490 ARG HIS GLY LYS GLU LEU ILE ASN PHE SER LYS ARG ARG SEQRES 32 A 490 LYS VAL ALA GLU ILE THR GLY GLU ILE GLN GLN TYR GLN SEQRES 33 A 490 ASN GLN PRO TYR CYS LEU ARG VAL GLU SER ASP ILE LYS SEQRES 34 A 490 ARG PHE PHE GLU ASN LEU ASN PRO MET GLY ASN SER MET SEQRES 35 A 490 GLU LYS GLU PHE THR ASP TYR LEU PHE ASN LYS SER LEU SEQRES 36 A 490 GLU ILE GLU PRO ARG ASN PRO LYS PRO LEU PRO ARG PHE SEQRES 37 A 490 PRO LYS LYS TYR SER TYR PRO LEU LYS SER PRO GLY VAL SEQRES 38 A 490 ARG PRO SER ASN PRO ARG PRO GLY THR HET AXH A2001 32 HET EDO A2002 4 HET EDO A2003 4 HET EDO A2004 4 HETNAM AXH 6,7-DIMETHOXY-2-METHYL-~{N}-[(1~{R})-1-[4-[2- HETNAM 2 AXH (METHYLAMINOMETHYL)PHENYL]THIOPHEN-2- HETNAM 3 AXH YL]ETHYL]QUINAZOLIN-4-AMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 AXH C25 H28 N4 O2 S FORMUL 3 EDO 3(C2 H6 O2) FORMUL 6 HOH *294(H2 O) HELIX 1 AA1 THR A 605 THR A 614 1 10 HELIX 2 AA2 ASP A 620 TYR A 631 1 12 HELIX 3 AA3 ARG A 632 PHE A 634 5 3 HELIX 4 AA4 LYS A 636 GLU A 649 1 14 HELIX 5 AA5 THR A 656 ASN A 665 1 10 HELIX 6 AA6 SER A 671 TYR A 681 1 11 HELIX 7 AA7 TYR A 681 HIS A 700 1 20 HELIX 8 AA8 PHE A 701 ASP A 707 1 7 HELIX 9 AA9 ASP A 707 THR A 720 1 14 HELIX 10 AB1 GLY A 723 ASP A 745 1 23 HELIX 11 AB2 HIS A 770 PHE A 774 5 5 HELIX 12 AB3 HIS A 780 ALA A 798 1 19 HELIX 13 AB4 GLN A 800 VAL A 808 5 9 HELIX 14 AB5 ASP A 813 SER A 818 1 6 HELIX 15 AB6 SER A 818 GLU A 841 1 24 HELIX 16 AB7 ASN A 844 LEU A 865 1 22 HELIX 17 AB8 ASN A 867 SER A 880 1 14 HELIX 18 AB9 SER A 880 ARG A 885 1 6 HELIX 19 AC1 LEU A 886 GLN A 892 1 7 HELIX 20 AC2 PRO A 894 LEU A 907 1 14 HELIX 21 AC3 SER A 908 ILE A 922 1 15 HELIX 22 AC4 PHE A 930 ASN A 944 1 15 HELIX 23 AC5 PHE A 958 GLN A 973 1 16 HELIX 24 AC6 GLU A 984 ASN A 993 1 10 HELIX 25 AC7 MET A 1001 GLU A 1017 1 17 SHEET 1 AA1 4 ILE A 586 PHE A 588 0 SHEET 2 AA1 4 ILE A 601 GLY A 604 -1 O ALA A 603 N ILE A 587 SHEET 3 AA1 4 LYS A 953 ASN A 957 -1 O ILE A 956 N GLY A 604 SHEET 4 AA1 4 VAL A 947 ARG A 950 -1 N LEU A 948 O LEU A 955 CISPEP 1 PRO A 924 PRO A 925 0 0.94 SITE 1 AC1 10 ASN A 879 VAL A 883 TYR A 884 LEU A 886 SITE 2 AC1 10 ASP A 887 PHE A 890 GLU A 902 HIS A 905 SITE 3 AC1 10 EDO A2004 HOH A2296 SITE 1 AC2 3 ASP A 775 TYR A1031 HOH A2140 SITE 1 AC3 3 ARG A 786 GLU A 864 PRO A1042 SITE 1 AC4 5 TYR A 884 ARG A 950 AXH A2001 HOH A2139 SITE 2 AC4 5 HOH A2184 CRYST1 39.476 84.281 175.285 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025332 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011865 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005705 0.00000